esonarimod has been researched along with ng-nitroarginine methyl ester in 1 studies
| Studies (esonarimod) | Trials (esonarimod) | Recent Studies (post-2010) (esonarimod) | Studies (ng-nitroarginine methyl ester) | Trials (ng-nitroarginine methyl ester) | Recent Studies (post-2010) (ng-nitroarginine methyl ester) |
|---|---|---|---|---|---|
| 33 | 1 | 8 | 12,640 | 117 | 2,342 |
| Protein | Taxonomy | esonarimod (IC50) | ng-nitroarginine methyl ester (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 2.7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.1 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.1167 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.6 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 8 | |
| Collagenase 3 | Homo sapiens (human) | 2.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, K; Hamada, Y; Higaki, M; Inoue, T; Takeshita, K | 1 |
1 other study(ies) available for esonarimod and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Line, Transformed; Cyclooxygenase 2; DNA Primers; DNA-Binding Proteins; Edema; Enzyme Inhibitors; Female; Gene Expression; Injections, Intravenous; Interferon Regulatory Factor-1; Interferon-beta; Isoenzymes; Lipopolysaccharides; Macrophages, Peritoneal; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phenylbutyrates; Phenylpropionates; Phosphoproteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |